Responses
Extended reports
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
Compose a Response to This Article
Other responses
No responses have been published for this article.